Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
Rong-Hua Zheng,1,2 Xiao-Jie Bai,1 Wei-Wei Zhang,1 Jing Wang,1 Feng Bai,1 Cai-Ping Yan,1 Erskine A James,3 Himangshu S Bose,4 Ning-Ping Wang,1,4 Zhi-Qing Zhao1,41Department of Physiology, Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Department of Medicine, Linfen...
Main Authors: | Zheng RH, Bai XJ, Zhang WW, Wang J, Bai F, Yan CP, James EA, Bose HS, Wang NP, Zhao Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/liraglutide-attenuates-cardiac-remodeling-and-improves-heart-function--peer-reviewed-article-DDDT |
Similar Items
-
The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling
by: Ran Li, et al.
Published: (2019-06-01) -
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
by: Qi Q, et al.
Published: (2017-07-01) -
Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
by: Zhang WW, et al.
Published: (2017-10-01) -
Management of hypertension: Insights into prescribing behavior with focus on angiotensin receptor blockers
by: S Ramakrishnan, et al.
Published: (2017-01-01) -
Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
by: Ivona Yanovna Yarek-Martynova, et al.
Published: (2010-06-01)